Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Any opinion on how the effectiveness of Brilacidin will hold up over time verses the reduction of effectiveness of Daptomycin due to bacteria evolution? The more times Brilacidin is compared to Daptomycin down the road, the one that inhibits antibiotic immunity issues will emerge the winner... that will be Brilacidin, and those in the know won't overlook this aspect.
a couple hours at this rate I am looking forward to the response the 10K brings...
The PR states "CytoSorbents expects to report 2013 revenues of approximately $2.4 million, ..." From the last 10k, 2012 was 1.34M, 2011 was 0.36M. Looking good CTSO!!!
Ah yes, I see that now - I had high hopes of it being 3 months after the last 10Q. Perhaps I will have more time to accumulate...
http://www.sec.gov/cgi-bin/browse-edgar?company=cytosorbents&owner=exclude&action=getcompany
Anyone know what day the next epic quarterly info gets released? I figure it's sometime between Monday and two weeks. And then we take this to the next level...
Another 100+% to go before the 'old' price target is met. I'm looking forward to the upcoming quarterly data. I wonder what the price targets will be revised to afterward... It will only go up!
Agreed, hope my bid fills before I have to raise it.
The room was full, nice, the applause at the end was much more full than the R&R conf. I'd venture to guess we close green tomorrow, but then I'm holding tight to all my shares so I may not be that fortunate. Will absolutely be buying on dips and holding as you suggest - spoken like a true profit, hehe, er prophet. Was CTIX's room more packed than CTSO's, if you watched both?
Nice PR! I bought this week
This just keeps getting better - I'll be looking for the right time to add more before the next quarterly info is released, no doubt it builds on the recent company momentum.
Sounds like we will be leaving small cap territory in the not so distant future - on our way to mid-cap, good enough for me!
BK, with 6 active trials, some Phase I, some Phase II, can you draw any comparisons with typical companies and come up with a ballpark market capitalization? Perhaps CTIX is in its own category? Thought your years of watching this sector might nail this question much better or more readily than I could. Regards.
Ain't no turd no more! Hope you hung in there, I've been in over 3 years myself, glad I stuck to watching the science over the SP over the years, things are going to get interesting with this one.
Tomorrow shall rock.
Hell yeah! Knew this one was going to start paying off.
How many people didn't see the Aspire deal coming last year? Oh - That's right, NO ONE saw it coming, now I remember Just say'n...
I noticed your question wasn't "will SBFM peak out at $1 this year?". So ... it might just blow right through $1? - Groovy!
CTIX? Well, as long as we're using gross generalities - anyone with Madoff in their name is a fool and deserves to be in jail. Oh - I'm sorry, there are exceptions? My bad - I didn't do my DD.
Nice 48k in buys at the end - they usually give them to you at bid price if they're large enough. Too bad the OTC algorithm records them as sells.
Nice try bunny ;) I also want more cheapies tomorrow!
The brokerages are making money off me this week, rotating out of others and into CTIX. I have no doubt all these commission payments will pay off in a big way.
Sorry, my order went in first, I got them :) I'm now up to the most I've ever owned! Feels nice!
Oral, topical, subcutaneous injection, eyedrops, smoke it, sniff it, anything to get it and put it in you is covered - I like that! (i.e., according to claim 2 and a pharmaceutically acceptable carrier.)
Right, claims 21 thru 24 are all independent claims without attached dependent claims anyway.
For example, because claim 17 ( A use according to claim 15 wherein said inflammatory disease is psoriasis.) refers to claim 15, claim 17 is a 'dependent claim', relying on the validity of claim 15. And claim 15 is also a dependent claim relying on one of claims 1-4 to be valid. If claims 1-4 were all not novel, then claim 15 and claim 17 would both cease to be novel as well.
There are no claims dependent upon claim 23 - so get it outta there!!! hehe
and... we're good.
That's how I read it anyways.
It all reminds me of the poster titled 'Physicists': "Just because you're not smart enough to know what [noretreat is] talking about doesn't mean [it's not correct]"
However - just because we've had an exponential decline in the frequency of PR's, one should not attempt to predict the future based on the past. Tomorrow's our day! I hope!
Radiation exposure - so the handouts of iodine pills (of which too much is toxic) occurred in mass after fukushima. I believe navy submariners are also provided iodine should a reactor malfunction occur in the deep. One day perhaps all these toxic remedies for radiation exposure will be replaced with a non-toxic oral form of Kevetrin... Preppers will be stocking their bunkers and hideouts at first chance.
Anyone else feel the tide shifting here? Green days ahead IMO.
Yep, a large portion of my holdings are long term and will stay there, I've been constantly accumulating recently as well...if only i had waited till this morning, haha.
Just like the good 'ol days a year ago - 15% intraday price swings :) last time this much action was happening, i accumulated a LOT.
So you're saying we shouldn't be concerned with the size of the waves, but that it's the motion of the ocean that counts? The motion of the CTIX ocean is taking us longs to promiseland!
Glad to see the climb at the end of day. BTW, words like lead balloon are nonsense for single digit percentage movements.
Today's purchases are going to look great in the near future!
Update your CTIX ticker please, it abated at 11:45
We all know what this company's products will be worth, do something about it - I'm a buyer today.
Hammer candle and at the 50dma... Two big turnaround signals!
Nice work! I knew green days would not stay away for long, we've really got something here with CTIX. Rally tomorrow anyone?
One thing that keeps me at peace: that "come to Jesus moment" that has been mentioned in prior posts today, when one must decide if/how/when/how much to hedge before that moment, well... IMO, we are still at least two or three dollars shy of that moment. I'm not concerned at all that my basis will be taken off at a much higher price before any pivotal news release happens. Anticipation alone will double the price. However, I am sure we won't be relying on anticipation alone - we will have some excellent progress reports constructed to the utmost standards and precision by the Cellceutix team along the way. Keep at peace and keep living the dream, cheers everyone and GO CTIX!
Me too, tells me that the only direction that volume will bring is up and up fast. Signs say buy.
Thanks. It doesn't take much for that to escalate.
6.01 is the average P/S, the multiplier can be much higher, for example Regeneron P/S is 15.14. If Kevetrin works even a fraction as well as in pre-clinical tests, the company in control will have a revenue stream well above par for the industry.
It's quite exciting!
Even at a 90% discount, if there was an investment out there that had no-brainer written all over it, we found it!
They put the adjective educated in front of the noun guess when mathematics and data are used in prediction - "educated guess"
So for those that might think I'm daydreaming, please at least agree to call it "educated daydreaming"
CTIX $800
Since we're all speculating - here are my scary numbers:
first look here for industry values
http://pages.stern.nyu.edu/~adamodar/New_Home_Page/datafile/psdata.html
Biotech Price per Revenue per Share (P/S) is 6.01 average as of Jan 2013.
Now we must make a BIG assumption, but lets make that assumption of revenue for curing cancer,psoriasis,etc. to be equal to $20B annually. We also must assume the fully diluted share count, let's say about 150M - I think everyone can agree that is close from prior discussions.
Now for the math:
6.01 = pps/(Revenue/Outstanding shares), or pps= 6.01*Revenue/Outstanding shares
pps=6.01*$20B/150M= $801.33
Now that is far in the future if Cellceutix were to get all the way through studies and then take market share, and develope to $20 Billion in Revenue... it could happen...
$800 WOW
Let me know if there are any gross errors in there.